Temat: "Anticoagulants" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Review of Medical Therapies for the Management of Pulmonary Embolism.
Autorzy :: Panahi L; Department of Pharmacy Practice, Texas A&M Rangel College of Pharmacy, 1010 W Ave B, Kingsville, TX 78363, USA.
Udeani G; Department of Pharmacy Practice, Texas A&M Rangel College of Pharmacy, 1010 W Ave B, Kingsville, TX 78363, USA.
Horseman M; Department of Pharmacy Practice, Texas A&M Rangel College of Pharmacy, 1010 W Ave B, Kingsville, TX 78363, USA.
Weston J; Department of Pharmacy Practice, Texas A&M Rangel College of Pharmacy, 1010 W Ave B, Kingsville, TX 78363, USA.
Samuel N; Department of Pharmacy Practice, Texas A&M Rangel College of Pharmacy, 1010 W Ave B, Kingsville, TX 78363, USA.
Joseph M; Department of Pharmacy Practice, Texas A&M Rangel College of Pharmacy, 1010 W Ave B, Kingsville, TX 78363, USA.
Mora A; Department of Pharmacy Practice, Texas A&M Rangel College of Pharmacy, 1010 W Ave B, Kingsville, TX 78363, USA.
Bazan D; Department of Pharmacy Practice, Texas A&M Rangel College of Pharmacy, 1010 W Ave B, Kingsville, TX 78363, USA.; Pokaż więcej
Źródło :: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2021 Jan 26; Vol. 57 (2). Date of Electronic Publication: 2021 Jan 26.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Anticoagulants/*therapeutic use
Fibrinolytic Agents/*therapeutic use
Pulmonary Embolism/*drug therapy
Administration, Oral ; Anticoagulants/administration & dosage ; COVID-19/complications ; Fibrinolytic Agents/administration & dosage ; Humans ; Liver Failure/complications ; Neoplasms/complications ; Renal Insufficiency/complications ; Risk Factors ; SARS-CoV-2
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: A retrospective analysis of dental implantation under anticoagulant treatment.
Autorzy :: Manor Y; Department of Oral and Maxillofacial Surgery, School of Dental Medicine, Tel Aviv University, Tel Aviv, Israel. .
Peleg O; Department of Oral and Maxillofacial Surgery, Sorasky Medical Center, Tel Aviv, Israel.
Mijiritsky E; Department of Oral and Maxillofacial Surgery, Sorasky Medical Center, Tel Aviv, Israel.
Manor A; Economical Unit, Edith Wolfson Medical Center, Holon, Israel.
Reiter S; Department of Oral Medicine, School of Dental Medicine, Tel Aviv University, Tel Aviv, Israel.; Pokaż więcej
Źródło :: Clinical oral investigations [Clin Oral Investig] 2021 Mar; Vol. 25 (3), pp. 1001-1009. Date of Electronic Publication: 2020 Jun 06.
Typ publikacji :: Journal Article
MeSH Terms :: Anticoagulants*/therapeutic use
Postoperative Hemorrhage*/prevention & control
Administration, Oral ; Aged ; Dental Implantation ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Association of anticoagulation dose and survival in hospitalized COVID-19 patients: A retrospective propensity score-weighted analysis.
Autorzy :: Ionescu F; Department of Internal Medicine, Beaumont Health System, OUWB School of Medicine, Royal Oak, MI, USA.
Jaiyesimi I; Department of Hematology and Oncology, Beaumont Health System, OUWB School of Medicine, Royal Oak, MI, USA.
Petrescu I; Department of Internal Medicine, Beaumont Health System, OUWB School of Medicine, Royal Oak, MI, USA.
Lawler PR; Peter Munk Cardiac Centre, University Health Network, and the Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.
Castillo E; Department of Radiation Oncology, Beaumont Health System, OUWB school of Medicine, Royal Oak, MI, USA.; Department of Computational and Applied Mathematics, Rice University, Houston, TX, USA.
Munoz-Maldonado Y; Department of Hematology and Oncology, Beaumont Health System, OUWB School of Medicine, Royal Oak, MI, USA.; Statistical Savvy Consulting, LLC, Georgetown, TX, USA.
Imam Z; Department of Internal Medicine, Beaumont Health System, OUWB School of Medicine, Royal Oak, MI, USA.
Narasimhan M; Division of Pulmonary and Critical Care Medicine, North Well, NY, USA.
Abbas AE; Department of Cardiovascular Medicine, Beaumont Health System, OUWB School of Medicine, Royal Oak, MI, USA.
Konde A; Department of Hematology and Oncology, Beaumont Health System, OUWB School of Medicine, Royal Oak, MI, USA.
Nair GB; Division of Pulmonary and Critical Care Medicine, Beaumont Health System, OUWB School of Medicine, Royal Oak, MI, USA.; Pokaż więcej
Źródło :: European journal of haematology [Eur J Haematol] 2021 Feb; Vol. 106 (2), pp. 165-174. Date of Electronic Publication: 2020 Nov 04.
Typ publikacji :: Journal Article; Multicenter Study
MeSH Terms :: Anticoagulants*/administration & dosage
Anticoagulants*/adverse effects
COVID-19*/blood
COVID-19*/complications
COVID-19*/drug therapy
COVID-19*/mortality
Hemorrhage*/blood
Hemorrhage*/drug therapy
Hemorrhage*/etiology
Hemorrhage*/mortality
Hospital Mortality*
Intensive Care Units*
SARS-CoV-2/*metabolism
Aged ; Aged, 80 and over ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Propensity Score ; Retrospective Studies ; Survival Rate
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Emergency Medicine Physician Attitudes toward Anticoagulant Initiation for Patients with Atrial Fibrillation.
Autorzy :: Hua H; Department of Neurology, University of Miami, Miami, FL 305-764-2120, United States. Electronic address: .
Sur N; Department of Neurology, University of Miami, Miami, FL 305-764-2120, United States.
Lee L; Emergency Department, Jackson Memorial Hospital, Miami, FL 305-585-6910, United States.
Chaturvedi S; Department of Neurology, University of Maryland, Baltimore, MD 410-328-4723, United States.; Pokaż więcej
Źródło :: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 Feb; Vol. 30 (2), pp. 105474. Date of Electronic Publication: 2020 Nov 23.
Typ publikacji :: Journal Article
MeSH Terms :: Attitude of Health Personnel*
Emergency Service, Hospital*
Health Knowledge, Attitudes, Practice*
Practice Patterns, Physicians'*
Primary Prevention*
Anticoagulants/*administration & dosage
Atrial Fibrillation/*drug therapy
Physicians/*psychology
Stroke/*prevention & control
Administration, Oral ; Anticoagulants/adverse effects ; Atrial Fibrillation/complications ; Atrial Fibrillation/diagnosis ; Clinical Decision-Making ; Cross-Sectional Studies ; Guideline Adherence ; Health Care Surveys ; Humans ; Practice Guidelines as Topic ; Stroke/diagnosis ; Stroke/etiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Safety and Efficacy of a Percutaneously Inserted Ventricular Support Device Purge Solution Heparin 25 U/mL.
Autorzy :: Jiang C; Henry Ford Health System, Detroit, MI, USA.
Stuart M; Henry Ford Health System, Detroit, MI, USA.
Makowski C; Henry Ford Health System, Detroit, MI, USA.
Jennings DL; NewYork-Presbyterian Hospital Columbia University Medical Center, New York, NY, USA.; Long Island University College of Pharmacy, New York, NY, USA.
To L; Henry Ford Health System, Detroit, MI, USA.; Pokaż więcej
Źródło :: The Annals of pharmacotherapy [Ann Pharmacother] 2021 Feb; Vol. 55 (2), pp. 174-180. Date of Electronic Publication: 2020 Aug 01.
Typ publikacji :: Journal Article; Observational Study
MeSH Terms :: Anticoagulants/*adverse effects
Heart-Assist Devices/*adverse effects
Heart-Assist Devices/*standards
Heparin/*adverse effects
Anticoagulants/administration & dosage ; Anticoagulants/therapeutic use ; Blood Coagulation/drug effects ; Cohort Studies ; Dose-Response Relationship, Drug ; Female ; Heart Ventricles/drug effects ; Hemodynamics/drug effects ; Hemorrhage/chemically induced ; Hemorrhage/epidemiology ; Heparin/administration & dosage ; Heparin/therapeutic use ; Humans ; Male ; Middle Aged ; Partial Thromboplastin Time ; Prevalence ; Retrospective Studies ; Shock, Cardiogenic/chemically induced ; Shock, Cardiogenic/drug therapy ; Thrombosis/chemically induced ; Thrombosis/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Improving Thermodynamic Stability and Anticoagulant Activity of a Thrombin Binding Aptamer by Incorporation of 8-trifluoromethyl-2'-deoxyguanosine.
Autorzy :: Bao HL; Division of Chemistry, Department of Medical Sciences, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.
Ishizuka T; Division of Chemistry, Department of Medical Sciences, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.
Yamashita A; Department of Pathology, Division of Pathophysiology, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.
Furukoji E; Department of Radiology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.
Asada Y; Department of Pathology, Division of Pathophysiology, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.
Xu Y; Division of Chemistry, Department of Medical Sciences, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.; Pokaż więcej
Źródło :: Journal of medicinal chemistry [J Med Chem] 2021 Jan 14; Vol. 64 (1), pp. 711-718. Date of Electronic Publication: 2020 Dec 08.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Anticoagulants/*metabolism
Aptamers, Nucleotide/*metabolism
Deoxyguanosine/*chemistry
Thrombin/*metabolism
Animals ; Anticoagulants/chemistry ; Anticoagulants/therapeutic use ; Aptamers, Nucleotide/chemistry ; Aptamers, Nucleotide/therapeutic use ; Circular Dichroism ; G-Quadruplexes ; Humans ; Male ; Models, Molecular ; Nuclear Magnetic Resonance, Biomolecular ; Protein Binding ; Prothrombin Time ; Rats ; Rats, Sprague-Dawley ; Thermodynamics ; Thrombin/chemistry ; Thrombosis/chemically induced ; Thrombosis/drug therapy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review.
Autorzy :: Vathiotis IA; 68989National and Kapodistrian University of Athens School of Medicine, Athens, Greece.; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
Syrigos NK; 68989National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Dimakakos EP; 68989National and Kapodistrian University of Athens School of Medicine, Athens, Greece.; Pokaż więcej
Źródło :: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [Clin Appl Thromb Hemost] 2021 Jan-Dec; Vol. 27, pp. 1076029620979592.
Typ publikacji :: Journal Article; Systematic Review
MeSH Terms :: Anticoagulants/*therapeutic use
Neoplasms/*complications
Renal Insufficiency/*complications
Tinzaparin/*therapeutic use
Venous Thromboembolism/*etiology
Venous Thromboembolism/*prevention & control
Anticoagulants/adverse effects ; Anticoagulants/pharmacokinetics ; Female ; Hemorrhage/etiology ; Humans ; Male ; Primary Prevention ; Prospective Studies ; Safety ; Secondary Prevention ; Tinzaparin/adverse effects ; Tinzaparin/pharmacokinetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Description of Bivalirudin Use for Anticoagulation in Pediatric Patients on Mechanical Circulatory Support.
Autorzy :: Campbell CT; University of Florida Health Shands Children's Hospital, Gainesville, FL, USA.; University of Florida College of Pharmacy, Gainesville, FL, USA.
Diaz L; University of Florida Health Shands Children's Hospital, Gainesville, FL, USA.
Kelly B; University of Florida Health Shands Children's Hospital, Gainesville, FL, USA.; Pokaż więcej
Źródło :: The Annals of pharmacotherapy [Ann Pharmacother] 2021 Jan; Vol. 55 (1), pp. 59-64. Date of Electronic Publication: 2020 Jun 26.
Typ publikacji :: Journal Article
MeSH Terms :: Extracorporeal Membrane Oxygenation*/adverse effects
Heart-Assist Devices*/adverse effects
Anticoagulants/*therapeutic use
Blood Coagulation/*drug effects
Peptide Fragments/*therapeutic use
Adult ; Anticoagulants/administration & dosage ; Anticoagulants/adverse effects ; Child ; Child, Preschool ; Cost-Benefit Analysis ; Dose-Response Relationship, Drug ; Female ; Hirudins/administration & dosage ; Hirudins/adverse effects ; Humans ; Male ; Partial Thromboplastin Time ; Peptide Fragments/administration & dosage ; Peptide Fragments/adverse effects ; Recombinant Proteins/administration & dosage ; Recombinant Proteins/adverse effects ; Recombinant Proteins/therapeutic use ; Retrospective Studies ; Thrombosis/etiology ; Thrombosis/prevention & control
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Retrospective Review of Prescribing Patterns in Cancer-Associated Thrombosis: A Single Center Experience in Edmonton, Alberta, Canada.
Autorzy :: Kaliel H; Pharmacy Services, 3146Alberta Health Services, Edmonton, Alberta, Canada.
Mior M; Pharmacy Services, 3146Alberta Health Services, Edmonton, Alberta, Canada.
Quan S; Pharmacy Services, 3146Alberta Health Services, Edmonton, Alberta, Canada.
Ghosh S; Pharmacy Services, 3146Alberta Health Services, Edmonton, Alberta, Canada.
Wu C; Division of Hematology, 3158University of Alberta, Edmonton, Alberta, Canada.; Co-senior author.
Bungard TJ; Division of Cardiology, 3158University of Alberta, Edmonton, Alberta, Canada.; Co-senior author.; Pokaż więcej
Źródło :: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [Clin Appl Thromb Hemost] 2021 Jan-Dec; Vol. 27, pp. 1076029620975489.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Anticoagulants/*therapeutic use
Neoplasms/*complications
Thrombosis/*drug therapy
Thrombosis/*etiology
Acute Disease ; Administration, Oral ; Aged ; Alberta ; Anticoagulants/administration & dosage ; Chronic Disease ; Female ; Heparin, Low-Molecular-Weight/therapeutic use ; Humans ; Male ; Middle Aged ; Practice Patterns, Physicians' ; Retrospective Studies ; Venous Thromboembolism/drug therapy ; Venous Thromboembolism/etiology ; Warfarin/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.
Autorzy :: Dufrost V; University of Lorraine, Inserm UMR_S 1116, CHRU de Nancy, Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, F-54000 Nancy, France.
Wahl D; University of Lorraine, Inserm UMR_S 1116, CHRU de Nancy, Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, F-54000 Nancy, France.
Zuily S; University of Lorraine, Inserm UMR_S 1116, CHRU de Nancy, Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, F-54000 Nancy, France. Electronic address: .; Pokaż więcej
Źródło :: Autoimmunity reviews [Autoimmun Rev] 2021 Jan; Vol. 20 (1), pp. 102711. Date of Electronic Publication: 2020 Nov 13.
Typ publikacji :: Journal Article; Meta-Analysis
MeSH Terms :: Anticoagulants*/adverse effects
Antiphospholipid Syndrome*/complications
Antiphospholipid Syndrome*/drug therapy
Venous Thromboembolism*/drug therapy
Administration, Oral ; Humans ; Randomized Controlled Trials as Topic ; Thrombosis ; Warfarin/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Pharmacologic therapeutic options for thromboprophylaxis in COVID-19.
Autorzy :: Kow CS; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia. .
Hasan SS; School of Applied Sciences, University of Huddersfield, Huddersfield, UK.; Pokaż więcej
Źródło :: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2021 Jan; Vol. 51 (1), pp. 29-30.
Typ publikacji :: Letter
MeSH Terms :: Anticoagulants*/administration & dosage
Anticoagulants*/classification
COVID-19*/blood
COVID-19*/complications
COVID-19*/therapy
Chemoprevention*/methods
Chemoprevention*/standards
Venous Thromboembolism*/diagnosis
Venous Thromboembolism*/etiology
Venous Thromboembolism*/prevention & control
Critical Illness/therapy ; Drug Administration Routes ; Humans ; Patient Selection ; SARS-CoV-2 ; Ultrasonography, Doppler, Duplex/methods
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: A prospective observational study of the rapid detection of clinically-relevant plasma direct oral anticoagulant levels following acute traumatic injury.
Autorzy :: Oberladstätter D; Department of Anaesthesiology and Intensive Care Medicine, AUVA Trauma Centre Salzburg, Academic Teaching Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.; Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Trauma Research Centre, Vienna, Austria.
Voelckel W; Department of Anaesthesiology and Intensive Care Medicine, AUVA Trauma Centre Salzburg, Academic Teaching Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.
Schlimp C; Department of Anaesthesiology and Intensive Care Medicine, AUVA Trauma Centre Salzburg, Academic Teaching Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.; Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Trauma Research Centre, Vienna, Austria.
Zipperle J; Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Trauma Research Centre, Vienna, Austria.
Ziegler B; Department of Anaesthesiology and Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria.
Grottke O; Department of Anaesthesiology, University Hospital of the RWTH Aachen, Aachen, Germany.
Schöchl H; Department of Anaesthesiology and Intensive Care Medicine, AUVA Trauma Centre Salzburg, Academic Teaching Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.; Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Trauma Research Centre, Vienna, Austria.; Pokaż więcej
Źródło :: Anaesthesia [Anaesthesia] 2021 Mar; Vol. 76 (3), pp. 373-380. Date of Electronic Publication: 2020 Sep 18.
Typ publikacji :: Journal Article; Observational Study
MeSH Terms :: Anticoagulants/*blood
Blood Coagulation/*drug effects
Blood Coagulation Tests/*methods
Wounds and Injuries/*blood
Acute Disease ; Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Anticoagulants/administration & dosage ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Sensitivity and Specificity
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: [Epistaxis and anticoagulation therapy: an analysis based on health insurance data from Lower Saxony].
Autorzy :: Althaus AE; Department für Versorgungsforschung, Abteilung Allgemeinmedizin, Carl von Ossietzky Universität Oldenburg, Oldenburg, Deutschland. .; Theaterwall 43, 26122, Oldenburg, Deutschland. .
Arendt U; Department für Versorgungsforschung, Abteilung Allgemeinmedizin, Carl von Ossietzky Universität Oldenburg, Oldenburg, Deutschland.
Hoffmann F; Department für Versorgungsforschung, Abteilung Ambulante Versorgung und Pharmakoepidemiologie, Carl von Ossietzky Universität Oldenburg, Oldenburg, Deutschland.
Lüske J; Praxis Dr. Lüske, Oldenburg, Deutschland.
Freitag MH; Department für Versorgungsforschung, Abteilung Allgemeinmedizin, Carl von Ossietzky Universität Oldenburg, Oldenburg, Deutschland.
Jobski K; Department für Versorgungsforschung, Abteilung Ambulante Versorgung und Pharmakoepidemiologie, Carl von Ossietzky Universität Oldenburg, Oldenburg, Deutschland.
Dörks M; Department für Versorgungsforschung, Abteilung Ambulante Versorgung und Pharmakoepidemiologie, Carl von Ossietzky Universität Oldenburg, Oldenburg, Deutschland.; Pokaż więcej
Transliterated Title :: Epistaxis und antithrombotische Medikation: eine Analyse der Daten einer gesetzlichen Krankenversicherung in Niedersachsen.
Źródło :: HNO [HNO] 2021 Mar; Vol. 69 (3), pp. 206-212.
Typ publikacji :: Journal Article
MeSH Terms :: Anticoagulants*/therapeutic use
Epistaxis*/epidemiology
Administration, Oral ; Humans ; Insurance, Health ; Male ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Anticoagulant management by low-dose of low molecular weight heparin in patients with nonvalvular atrial fibrillation following hemorrhagic transformation and complicated with venous thrombosis: Five case reports and literature review.
Autorzy :: Zhang L; Department of Rehabilitation, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing City, China.
Kong YH
Wang DW
Li KT
Yu HP; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2021 Feb 19; Vol. 100 (7), pp. e24189.
Typ publikacji :: Case Reports; Journal Article; Review
MeSH Terms :: Anticoagulants/*administration & dosage
Atrial Fibrillation/*drug therapy
Heparin, Low-Molecular-Weight/*administration & dosage
Stroke/*prevention & control
Venous Thrombosis/*drug therapy
Aged ; Aged, 80 and over ; Anticoagulants/adverse effects ; Female ; Heparin, Low-Molecular-Weight/adverse effects ; Humans ; Male ; Middle Aged ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Inhibition of Tumor-Host Cell Interactions Using Synthetic Heparin Mimetics.
Autorzy :: Gockel LM; Pharmaceutical Institute, Pharmaceutical and Cell Biological Chemistry, University of Bonn, 53121 Bonn, Germany.
Heyes M; Pharmaceutical Institute, Pharmaceutical and Cell Biological Chemistry, University of Bonn, 53121 Bonn, Germany.
Li H; Department of Medical Biochemistry and Microbiology, SciLifeLab Uppsala, The Biomedical Center, University of Uppsala, 75123 Uppsala, Sweden.
Al Nahain A; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4072, Australia.; Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland 4072, Australia.
Gorzelanny C; Experimental Dermatology, Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Schlesinger M; Pharmaceutical Institute, Pharmaceutical and Cell Biological Chemistry, University of Bonn, 53121 Bonn, Germany.
Holdenrieder S; The German Heart Centre of Technical University Munich, Laboratory Medicine, 80636 Munich, Germany.
Li JP; Department of Medical Biochemistry and Microbiology, SciLifeLab Uppsala, The Biomedical Center, University of Uppsala, 75123 Uppsala, Sweden.
Ferro V; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4072, Australia.; Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland 4072, Australia.
Bendas G; Pharmaceutical Institute, Pharmaceutical and Cell Biological Chemistry, University of Bonn, 53121 Bonn, Germany.; Pokaż więcej
Źródło :: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2021 Feb 17; Vol. 13 (6), pp. 7080-7093. Date of Electronic Publication: 2021 Feb 03.
Typ publikacji :: Journal Article
MeSH Terms :: Anticoagulants/*pharmacology
Heparin, Low-Molecular-Weight/*pharmacology
Melanoma/*drug therapy
Anticoagulants/chemistry ; Cell Adhesion/drug effects ; Cell Line, Tumor ; Endothelial Cells/drug effects ; Heparin, Low-Molecular-Weight/chemistry ; Humans ; Melanoma/pathology ; Molecular Structure ; Particle Size ; Surface Properties
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study.
Autorzy :: Rentsch CT; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK .; VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, USA.
Beckman JA; Cardiovascular Division, Vanderbilt University Medical Center and Vanderbilt Translational and Clinical Cardiovascular Research Center, Nashville, TN, USA.
Tomlinson L; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.
Gellad WF; Center for Pharmaceutical Policy and Prescribing, Health Policy Institute, University of Pittsburgh, Pittsburgh, PA, USA.; Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Veterans Affairs Pittsburgh Healthcare System, US Department of Veterans Affairs, Pittsburgh, PA, USA.
Alcorn C; Center for Occupational Biostatistics and Epidemiology, Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Kidwai-Khan F; VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, USA.; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Skanderson M; VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, USA.
Brittain E; Department of Medicine, Vanderbilt University Medical Center and Vanderbilt Translational and Clinical Cardiovascular Research Center, Nashville, TN, USA.
King JT Jr; VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, USA.; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
Ho YL; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, USA.
Eden S; Faculty of Biostatistics, Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA.
Kundu S; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Lann MF; Center for Occupational Biostatistics and Epidemiology, Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Greevy RA Jr; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Ho PM; Rocky Mountain Regional VA Medical Center, US Department of Veterans Affairs, Aurora, CO, USA.
Heidenreich PA; VA Palo Alto Healthcare System, US Department of Veterans Affairs, Palo Alto, CA, USA.; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Jacobson DA; Oak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, USA.
Douglas IJ; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.
Tate JP; VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, USA.; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Evans SJW; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.
Atkins D; Health Services Research and Development, US Department of Veterans Affairs, Washington, DC, USA.
Justice AC; VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, USA.; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.; Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA.
Freiberg MS; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Geriatric Research Education and Clinical Center, Tennessee Valley Healthcare System, US Department of Veterans Affairs, Nashville, TN, USA.; Pokaż więcej
Źródło :: BMJ (Clinical research ed.) [BMJ] 2021 Feb 11; Vol. 372, pp. n311. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :: Anticoagulants/*therapeutic use
COVID-19/*mortality
Enoxaparin/*therapeutic use
Thromboembolism/*prevention & control
Adult ; Aged ; Aged, 80 and over ; Anticoagulants/adverse effects ; COVID-19/complications ; Enoxaparin/adverse effects ; Female ; Hemorrhage/chemically induced ; Humans ; Male ; Middle Aged ; Patient Admission ; SARS-CoV-2 ; Thromboembolism/virology ; Time Factors ; United States/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: When Is It Safe to Start Pharmacologic Venous Thromboembolism Prophylaxis After Pelvic Fractures? A Prospective Study From a Level I Trauma Center.
Autorzy :: Schellenberg M; Division of Trauma and Surgical Critical Care, LAC+USC Medical Center, University of Southern California, Los Angeles, California. Electronic address: .
Benjamin E; Division of Trauma and Surgical Critical Care, LAC+USC Medical Center, University of Southern California, Los Angeles, California.
Inaba K; Division of Trauma and Surgical Critical Care, LAC+USC Medical Center, University of Southern California, Los Angeles, California.
Heindel P; Division of Trauma and Surgical Critical Care, LAC+USC Medical Center, University of Southern California, Los Angeles, California.
Biswas S; Division of Trauma and Surgical Critical Care, LAC+USC Medical Center, University of Southern California, Los Angeles, California.
Mooney JL; Section of Trauma/Critical Care Surgery, LSU Health Sciences Center, Louisiana State University, New Orleans, Louisiana.
Demetriades D; Division of Trauma and Surgical Critical Care, LAC+USC Medical Center, University of Southern California, Los Angeles, California.; Pokaż więcej
Źródło :: The Journal of surgical research [J Surg Res] 2021 Feb; Vol. 258, pp. 272-277. Date of Electronic Publication: 2020 Oct 08.
Typ publikacji :: Comparative Study; Journal Article; Observational Study
MeSH Terms :: Anticoagulants/*administration & dosage
Hemorrhage/*chemically induced
Pelvic Bones/*injuries
Platelet Aggregation Inhibitors/*administration & dosage
Venous Thromboembolism/*prevention & control
Adult ; Anticoagulants/adverse effects ; Chemoprevention/adverse effects ; Female ; Fractures, Bone ; Humans ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/adverse effects ; Prospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Management of Intracranial Hemorrhage in Patients with a Left Ventricular Assist Device: A Systematic Review and Meta-Analysis.
Autorzy :: Carroll AH; Georgetown University School of Medicine, Washington, D.C., USA.
Ramirez MP; Georgetown University School of Medicine, Washington, D.C., USA.
Dowlati E; Department of Neurosurgery, MedStar Georgetown University Hospital, Washington, D.C., USA. Electronic address: .
Mueller KB; Department of Neurosurgery, Rhode Island Hospital, Warren Alpert Medical School at Brown University, Providence, R.I., USA.
Borazjani A; Georgetown University School of Medicine, Washington, D.C., USA.
Chang JJ; Department of Critical Care Medicine, MedStar Washington Hospital Center, Washington D.C., USA.
Felbaum DR; Department of Neurosurgery, MedStar Washington Hospital Center, Washington, D.C., USA; Department of Neurosurgery, MedStar Georgetown University Hospital, Washington, D.C., USA.; Pokaż więcej
Źródło :: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 Feb; Vol. 30 (2), pp. 105501. Date of Electronic Publication: 2020 Dec 01.
Typ publikacji :: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :: Blood Transfusion*/mortality
Heart-Assist Devices*
Neurosurgical Procedures*/adverse effects
Neurosurgical Procedures*/mortality
Anticoagulants/*administration & dosage
Coagulants/*administration & dosage
Heart Failure/*therapy
Intracranial Hemorrhages/*therapy
Platelet Aggregation Inhibitors/*administration & dosage
Prosthesis Implantation/*instrumentation
Adult ; Aged ; Anticoagulants/adverse effects ; Coagulants/adverse effects ; Drug Administration Schedule ; Female ; Heart Failure/diagnosis ; Heart Failure/mortality ; Heart Failure/physiopathology ; Humans ; Incidence ; Intracranial Hemorrhages/diagnostic imaging ; Intracranial Hemorrhages/mortality ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/adverse effects ; Prosthesis Implantation/adverse effects ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome ; Ventricular Function, Left
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Association Between the Prothrombin Time-International Normalized Ratio and Concomitant Use of Antibiotics in Warfarin Users: Focus on Type of Antibiotic and Susceptibility of Bacteroides fragilis to Antibiotics.
Autorzy :: Yagi T; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.; Department of Medicine Solna, Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Naito T; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kato A; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Hirao K; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kawakami J; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.; Pokaż więcej
Źródło :: The Annals of pharmacotherapy [Ann Pharmacother] 2021 Feb; Vol. 55 (2), pp. 157-164. Date of Electronic Publication: 2020 Jul 07.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: International Normalized Ratio*
Prothrombin Time*
Anti-Bacterial Agents/*adverse effects
Anticoagulants/*administration & dosage
Blood Coagulation/*drug effects
Warfarin/*administration & dosage
Aged ; Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/therapeutic use ; Anticoagulants/therapeutic use ; Bacterial Infections/drug therapy ; Bacterial Infections/microbiology ; Bacteroides fragilis/drug effects ; Cohort Studies ; Drug Interactions ; Female ; Fluoroquinolones/administration & dosage ; Fluoroquinolones/adverse effects ; Fluoroquinolones/therapeutic use ; Hemorrhage/chemically induced ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Warfarin/therapeutic use ; beta-Lactams/administration & dosage ; beta-Lactams/adverse effects ; beta-Lactams/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Early Thromboprophylaxis in Operative Spinal Trauma Does Not Increase Risk of Bleeding Complications.
Autorzy :: Hamidi M; Division of Trauma, Critical Care, Emergency Surgery, and Burns, Department of Surgery, College of Medicine, University of Arizona, Tucson, Arizona.
Asmar S; Division of Trauma, Critical Care, Emergency Surgery, and Burns, Department of Surgery, College of Medicine, University of Arizona, Tucson, Arizona.
Bible L; Division of Trauma, Critical Care, Emergency Surgery, and Burns, Department of Surgery, College of Medicine, University of Arizona, Tucson, Arizona.
Hanna K; Division of Trauma, Critical Care, Emergency Surgery, and Burns, Department of Surgery, College of Medicine, University of Arizona, Tucson, Arizona.
Castanon L; Division of Trauma, Critical Care, Emergency Surgery, and Burns, Department of Surgery, College of Medicine, University of Arizona, Tucson, Arizona.
Avila M; Division of Trauma, Critical Care, Emergency Surgery, and Burns, Department of Surgery, College of Medicine, University of Arizona, Tucson, Arizona.
Ditillo M; Division of Trauma, Critical Care, Emergency Surgery, and Burns, Department of Surgery, College of Medicine, University of Arizona, Tucson, Arizona.
Joseph B; Division of Trauma, Critical Care, Emergency Surgery, and Burns, Department of Surgery, College of Medicine, University of Arizona, Tucson, Arizona. Electronic address: .; Pokaż więcej
Źródło :: The Journal of surgical research [J Surg Res] 2021 Feb; Vol. 258, pp. 119-124. Date of Electronic Publication: 2020 Sep 30.
Typ publikacji :: Journal Article
MeSH Terms :: Anticoagulants/*administration & dosage
Hemorrhage/*chemically induced
Heparin, Low-Molecular-Weight/*administration & dosage
Spinal Injuries/*complications
Venous Thromboembolism/*prevention & control
Adult ; Aged ; Anticoagulants/adverse effects ; Female ; Heparin, Low-Molecular-Weight/adverse effects ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Spinal Injuries/surgery
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Anticoagulants"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język